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ABSTRACT
Reverse genetics has become pivotal in influenza
virus research relying on rapid generation of tailored
recombinant influenza viruses. They are rescued
from transfected plasmids encoding the eight influ-
enza virus gene segments, which have been cloned
using restriction endonucleases and DNA ligation.
However, suitable restriction cleavage sites often
are not available. Here, we describe a cloning
method universal for any influenza A virus strain
which is independent of restriction sites. It is
based on target-primed plasmid amplification in
which the insert provides two megaprimers and
contains termini homologous to plasmid regions
adjacent to the insertion site. For improved effi-
ciency, a cloning vector was designed containing
the negative selection marker ccdB flanked by the
highly conserved influenza A virus gene termini.
Using this method, we generated complete sets of
functional gene segments from seven influenza A
strains and three haemagglutinin genes from differ-
ent serotypes amounting to 59 cloned influenza
genes. These results demonstrate that this
approach allows rapid and reliable cloning of any
segment from any influenza A strain without any
information about restriction sites. In case the
PCR amplicon ends are homologous to the plasmid
annealing sites only, this method is suitable for
cloning of any insert with conserved termini.
INTRODUCTION
Many studies in life sciences are based on the eﬃcient
generation of multiple plasmid constructs in parallel.
Several high-throughput cloning methods are available
for generating entire libraries of open reading frames (1).
However, for some purposes, it is essential that the
inserted cDNA has to be transcribed into RNA of precise
length without any additional terminal nucleotides and,
therefore, its insertion into an expression cassette is con-
ﬁned to exact nucleotide positions. This constraint also
applies to reverse genetics of inﬂuenza A viruses. Basic
research and vaccine development have been expedited
by the generation of recombinant inﬂuenza A viruses
solely from plasmids (2–6). However, established systems
require prior cleavage of amplicons with terminal restric-
tion cleavage sites susceptible to outside cutter enzymes
like BsmBI (7) prior to insertion into appropriately
cleaved plasmid vectors. Unfortunately, viral genes may
contain internal restriction cleavage sites for all available
enzymes of this type generating a compatible overhang. At
present, this requires subcloning and subsequent removal
of unwanted internal restriction cleavage sites before clon-
ing. Such additional time-consuming steps can be diﬀerent
in each case and require prior sequence information of the
insert.
Therefore, we sought to establish a cloning method
which is independent of restriction enzyme cleavage but
still yields high numbers of positive clones. Geiser et al.
described a modiﬁed Quikchange
TM site-directed muta-
genesis protocol designed to introduce entire PCR ampli-
cons into plasmids by insertion between two neighboured
nucleotides or by exchange of an entire vector region,
whereby the two strands of the PCR amplicon serve as
megaprimers. Each megaprimer anneals to the plasmid
at the complementary site and is then elongated from its
30-end by the DNA polymerase. The maximum length of
successfully cloned inserts in this study was 1117bp (8),
whereas the longest inﬂuenza A virus genes (PB2, PB1)
each comprise 2341nt. In order to improve cloning eﬃ-
ciency, we inserted into the plasmid pHW2000 the con-
served inﬂuenza gene termini (9) and between them the
negative selection marker ccdB (10). By use of appropriate
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gous annealing sites, but allows shorter PCR primers to be
used thus securing eﬃcient ampliﬁcation. Using this novel
assay, we were able to clone the complete genomic sets of
eight segments from seven inﬂuenza A virus strains and
three haemagglutinin genes from strains with subtypes H4,
H6 and H8 amounting to a total 59 functional viral genes.
These results demonstrate that our approach is suitable
for rapid and reliable cloning of basically any insert with
conserved termini without any prior information about
restriction sites.
MATERIALS AND METHODS
Viruses
Inﬂuenza A/Thailand/1(KAN-1)/2004 (H5N1) was propa-
gated in MDCK cells, whereas the strains A/Swan/R65/
2006 (H5N1), A/Swine/Belzig/2/2001 (H1N1), A/Denver/
57 (H1N1), A/Duck/Ukraine/1/1963 (H3N8), A/Hong
Kong/1/1968 (H3N2), A/Chicken/Emirates/R66/2002
(H9N2), A/Mallard/Germany/1740/1/07 (H4N6),
A/Turkey/Germany/R617/07 (H6N2) and A/Turkey/
Ontario/6118/68 (H8N4) were grown in embryonated
hen eggs.
Generationof theplasmid pHWSccdB
For ampliﬁcation of the ccdB gene from the Gateway
TM
conversion cassette (Invitrogen GmbH) (nt from 897 to
1583 of reading frame cassette A), we used primers with
elongated 50-ends containing the conserved inﬂuenza A
gene termini and adjacent BsmBI restriction cleavage
sites. The primer sequences were:
50-ATATCGTCTCAGGGAGCAAAAGCAGGACG
CGTGGATCCGGC-30 and
50-ATATCGTCTCTTATTAGTAGAAACAAGGGT
CGACCTGCAGACTG-30.
The forward primer contains 12nt from the 50-end of
inﬂuenza A cRNA (underlined) and the reverse primer
13nt from 50-end of inﬂuenza A vRNA (underlined).
After digestion of the PCR amplicon and recipient plas-
mid pHW2000 with BsmBI, the resulting fragments were
ligated and an aliquot was transformed into ccdB-resistant
DB 3.1
TM bacteria (Invitrogen).
Primers
For ampliﬁcation of inﬂuenza A virus genes, we used pri-
mers modiﬁed from ref. (11) (Table 1). The forward
primer PHW-PB1-17F was newly designed by extending
its 30-end with additional conserved nucleotides (results
from Blast query not shown), because the primer with
the original 30-end caused erroneous ampliﬁcation and
subsequent integration of the PA gene instead of PB1
into pHWSccdB. For the neuraminidase gene, four
primer pairs should be designed according to the subtype
(separately for N1, N2, N4, N5, N8; for N3; for N6, N7;
and for N9) (11).
RT– PCR fromisolated RNA
Viral RNA was isolated with the QIAamp Viral RNA Kit
(Qiagen, Hilden, Germany) according to manufacturer’s
instructions and reverse-transcribed using Omniscript RT
Kit (Qiagen) along with a primer complementary to the
conserved 12nt of 30-end of the viral RNA (primer Uni12)
(11). Using gene-speciﬁc primers two microlitres of each
RT reaction were subjected to PCR (total reaction volume
100ml) by an initial denaturation step (988C 30s), followed
by 35 cycles each consisting of 988C1 0s ,6 0 8C3 0s ,7 2 8C
6min and ﬁnal elongation (728C 5min) utilizing 2 U
Phusion High-Fidelity DNA Polymerase (New England
BioLabs, Frankfurt am Main, Germany) according to
the manufacturer’s instructions. For determination of
fragment sizes and quantiﬁcation of amplicons, we used
Table 1. Primer set used for PCR ampliﬁcation of inﬂuenza A virus genes
Gene Forward primer Reverse primer Expected size (bp)
PB2 PHW-PB2f: PHW-PB2-2341r: 2341+26
gaagttggggggg agcgaaagcaggTC ccgccgggttatt agtagaaacaaggTCGTTT
PB1 PHW-PB1-17f: PHW-PB1-2341r: 2341+26
gaagttggggggg agcgaaagcaggCAAAC ccgccgggttatt agtagaaacaaggCATTT
PA PHW-PAf: PHW-PA-2233r: 2233+26
gaagttggggggg agcgaaagcaggTAC ccgccgggttatt agtagaaacaaggTACTT
HA PHW-HAf: identical with PHW-NSr 1779+26
gaagttggggggg agcaaaagcaggGG
NP PHW-NPf: PHW-NPr: 1565+26
gaagttggggggg agcaaaagcaggGTA ccgccgggttatt agtagaaacaaggGTATTTTT
NA PHW-N12458f: PHW-N12458r: 1399+26
gaagttggggggg agcaaaagcaggAGT ccgccgggttatt agtagaaacaaggAGT
M PHW-Mf: PHW-Mr: 1027+26
gaagttggggggg agcaaaagcaggTAG ccgccgggttatt agtagaaacaaggTAG
NS PHW-NSf: PHW-NSr: 875+26
gaagttggggggg agcaaaagcaggGTG ccgccgggttatt agtagaaacaaggGTG
Primers are modiﬁed from universal inﬂuenza A primers
11. Their 50ends (italic) are derived from pHW2000 regions preceding the viral gene termini
followed by the conserved inﬂuenza A virus gene termini (lowercase), and conserved gene-speciﬁc nucleotides at the 30 ends (uppercase bold). The
expected size of the PCR products is based on the length of the genes of strain A/Thailand/1(KAN-1)/2004 (H5N1) plus the noninﬂuenza sequences
and may diﬀer slightly in case of HA, NA and the NS genes from those of other inﬂuenza A isolates.
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TM DNA ladder (Mix) (Fermentas, St
Leon-Rot, Germany).
Target-primed plasmid amplification andtransformation
Target-primed plasmid ampliﬁcation was performed with
100ng pHWSccdB plasmid and PCR amplicon, which had
been agarose-gel puriﬁed and pooled from 1 to 6 PCR
reactions, using 2 U Phusion High-Fidelity DNA Poly-
merase according to manufacturer’s instructions (total
reaction volume 50ml). The amount of PCR amplicon
was determined using ImageJ 1.38X (12) from a calibrated
image of an agarose gel electrophoresis run including
quantitative DNA standards. An initial denaturation
step (988C 30s) was followed by 35 cycles each consisting
of 988C1 0s ,4 8 8C 1min and 728C 5:30min. Prior to trans-
formation into bacteria, which are not completely sensi-
tive to ccdB [such as the SURE2
TM, Xl1-Blue
TM or XL-10
Gold
TM strains (Stratagene Europe, Amsterdam,
The Netherlands)], cleavage with DpnI (New England
Biolabs (UK) Ltd.) was performed in order to remove
the methylated parent plasmid pHWSccdB and any hemi-
methylated hybrid molecules. In case of the TOP10
TM
strain (Invitrogen Ltd, UK) which is fully sensitive to
ccdB, this step is not required. Following target-primed
plasmid ampliﬁcation, 1, 5 or 10ml of the reaction mixture
were transformed into TOP10
TM, SURE2
TM, Xl1-Blue
TM
or XL-10 Gold
TM bacteria according to the manufac-
turer’s instructions.
Virus rescue bytransfection ofplasmids
Cloned genes from all virus strains except the haemagglu-
tinins of the highly pathogenic H5N1 isolates A/Thailand/
1(KAN-1)/2004 and A/Swan/R65/2006 were tested by
cotransfection (13) with seven plasmids encoding the
genes of A/WSN/33 (2) or the hvPR8 strain (14). A plas-
mid clone was demonstrated to be functional by the
appearance of a cytopathic eﬀect on MDCK cells and
positive haemagglutination test from the supernatant.
RESULTS
Interdependent designof cloning vector pHWSccdB
and PCR primers
For the introduction of entire PCR amplicons into plas-
mids by target-primed plasmid ampliﬁcation, homologous
termini are required (8). Therefore, we extended the
50-ends of universal inﬂuenza A primers (11) to achieve
homology to the cloning vector pHW2000 (2). However,
these primers with a resulting size of 40nt performed only
poorly in the PCR (data not shown). This result could be
attributed to the high GC-content of the adjacent vector
regions. Therefore, in order to secure high PCR yields in
combination with the required homology with vector
sequences of at least 20nt and for high cloning eﬃciency,
we introduced into pHW2000 the conserved inﬂuenza A
gene termini (9) and between them the negative selection
marker ccdB resulting in plasmid pHWSccdB (Figure 1).
A set of eight primer pairs is required for full-length
ampliﬁcation of all inﬂuenza virus genomic segments.
These primers are based on the universal inﬂuenza A pri-
mers (11) with modiﬁcations (Table 1). Their 50-ends con-
sist of 13nt homologous to vector sequences preceding
the inﬂuenza A gene termini in pHWSccdB. This interde-
pendent design of primers and plasmid vector resulted in
terminal homologous regions of 25 and 26nt between
amplicon and vector (Figure 1 and Table 1) allowing the
use of shorter PCR primers, which ensured eﬃcient ampli-
ﬁcation. In addition, the introduced ccdB gene enables
selection against parental pHWSccdB after transformation
into ccdB-sensitive bacteria such as the TOP10
TM strain.
Universal influenza APCR and target-primed plasmid
amplification
To clone the complete set of all eight genomic segments of
inﬂuenza A/Thailand/1(KAN-1)/2004 (H5N1) (15), viral
RNA was reverse-transcribed and ampliﬁed by the modi-
ﬁed universal inﬂuenza A virus PCR (11) (Figure 1). For
ampliﬁcation of the neuraminidase gene of strain A/
Thailand/1(KAN-1)/2004 (H5N1) (15), the appropriate
primer pair was used. Since the gene-speciﬁc primers
diﬀer at their 30-ends by only a few nucleotides
(Table 1), other viral genes may be co-ampliﬁed. To
assure insertion of the correct amplicon, for each of the
eight viral genes, three PCR reactions were pooled (for
PB1 only one reaction was used) and amplicons of correct
size (Figure 2) were isolated from an agarose gel and used
for target-primed plasmid ampliﬁcation.
PCR amplicon = 2 Megaprimers
ccttgtttctact aataacccggcgg
ggaacaaagatga    ttattgggccgcc
gaagttggggggg   agcgaaagcagg
cttcaaccccccc tcgctttcgtcc
influenza A virus gene
5′-
3′- - 5′ 
- 3′
pHWSccdB
Annealing site to
3′ end of megaprimer
pHW2000
vRNA 5′ end
cRNA 5′ end
Annealing site to
3′ end of megaprimer
gaagttggggggg agcgaaagcagg
cttcaaccccccc tcgctttcgtcc
ccttgtttctact    aataacccggcgg
ggaacaaagatga ttattgggccgcc
Annealing of Each Megaprimer
to Its Complementary
Binding Site
Annealing site
to 3′ end of megaprimer
pHW2000
vRNA 5′ end
cttcaaccccccc    tcgctttcgtcc
ccttgtttctactaataacccggcgg gaagttggggggg    agcgaaagcagg 5′- - 3′
ggaacaaagatga ttattgggccgcc ccdB
ccdB
Figure 1. Schematic representation of PCR amplicon and plasmid
pHWSccdB. The two strands of the PCR amplicon serve as megapri-
mers. Each 30-end of the megaprimer anneals to the complementary
annealing site within the plasmid pHWSccdB and is elongated during
target-primed plasmid ampliﬁcation leading to replacement of the ccdB
marker by the viral gene. The two newly synthesized strands hybridize
to nicked circular molecules.
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Figure 3) were used together with the uncleaved
pHWSccdB for the target-primed plasmid ampliﬁcation.
Then, an aliquot was transformed into competent
Xl1-Blue
TM bacteria. For cloning of the PB1 gene,
SURE2
TM bacteria had to be used for transformation.
The amount of DNA transformed was  1ng. If the bac-
teria are not completely sensitive to ccdB selection, the
DNA should be digested with DpnI prior to transforma-
tion in order to select against unmodiﬁed methylated
pHWSccdB and hemimethylated hybrid molecules.
The numbers of bacterial colonies after transformation
ranged from 5 to 150 per plate. Insertion of the respective
fragment was conﬁrmed by restriction enzyme cleavage
with NheI and sequencing (data not shown). From the
analyzed clones, 75–100% carried an insert of the expected
size (Table 2). These data demonstrate that our cloning
method does not require prior knowledge of restriction
sites of the insert and yields a high rate of positive
clones. Using this method, we generated plasmid sets of
all eight gene segments representing the entire genomes
of the seven inﬂuenza A virus strains A/Thailand/
1(KAN-1)/2004 (H5N1), A/Swan/R65/2006 (H5N1), A/
Swine/Belzig/2/2001 (H1N1), A/Duck/Ukraine/1/1963
(H3N8), A/HongKong/1/1968 (H3N2), A/Denver/57
(H1N1) and A/Chicken/Emirates/R66/2002 (H9N2) as
well as of three haemagglutinin genes of strains
A/Mallard/Germany/1740/1/07 (H4N6), A/Turkey/
Germany/R617/07 (H6N2) and A/Turkey/Ontario/6118/
68 (H8N4). For transformation, we used TOP10
TM,
XL1-Blue
TM or XL10-Gold
TM and in case of some PB1
genes SURE2
TM bacteria. No sequence information rele-
vant for cloning had been available from 18 of those viral
genes [all eight genes from both A/Swine/Belzig/2/2001
(H1N1) and A/Chicken/Emirates/R66/2002 (H9N2), and
haemagglutinin genes of A/Mallard/Germany/1740/1/
07 (H4N6) and A/Turkey/Germany/R617/07 (H6N2)].
Taken together, 59 inﬂuenza virus genes were cloned
using target-primed plasmid ampliﬁcation. Except for the
haemagglutinin genes of the highly pathogenic H5N1
strains A/Thailand/1(KAN-1)/2004 and A/Swan/R65/
2006, which require enhanced security precautions
(BSL3+ conditions), all cloned genes were tested in virus
rescue and found to be functional. From strains A/Swine/
S
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Figure 2. Full-length PCR amplicons from genes of the strain A/
Thailand/1(KAN-1)/2004 (H5N1). Lanes: S DNA size marker (3ml),
PCR from H2O control ( ) and from cDNA transcribed from viral
RNA (+) (each 5ml from 100ml total reaction volume).
Table 2. Cloning eﬃciency: numbers of colonies and of clones with
correct length
Viral
Gene
Length
(nt)
PCR
amplicon
(ng)
Transformed
(ml)
Bacteria
colonies
Correct clones/
Number
analyzed
PB2 2341 120 1 0 11/12
120 10 34
PB1 2341 40 1 60 14/16
40 10 20
PA 2233 600 1 5 6/8
600 10 92
HA 1779 490 1 26 8/8
490 10 65
NP 1565 500 1 23 8/8
500 10 48
NA 1399 430 1 18 4/5
430 10 39
M 1027 150 1 12 8/8
150 10 140
NS 875 690 1 19 12/12
690 10 150
Numbers of bacteria colonies (XL1-Blue
TM bacteria, in case of the PB1
gene SURE2
TM bacteria) and of positive plasmid clones carrying the
cDNA of viral genes from strain A/Thailand/1(KAN-1)/2004 (H5N1)
with correct length in relation to viral gene length, approximate
amounts of PCR amplicons used for target-primed plasmid ampliﬁca-
tion and amounts of it used for transformation.
1000 bp
1500 bp
2000 bp
2500 bp
900 bp
1000 bp 
1500 bp
2000 bp
2500 bp
900 bp
S
S
PB2
PB1
PA
HA
NP
NA
NS
M
Figure 3. Puriﬁed PCR amplicons used as megaprimers for target-
primed plasmid ampliﬁcation. For each lane, three PCR assays (each
100ml) were pooled and agarose-gel puriﬁed (total volume 50ml), except
for PB1 for which only one assay was used. Lanes: S DNA size marker
(3ml) and puriﬁed amplicons (each 5ml).
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A/HongKong/1/1968 (H3N2) and A/Denver/57 (H1N1)
fully homologous recombinant viruses could be rescued
after transfection of the complete plasmid sets.
DISCUSSION
Reverse genetics of inﬂuenza A viruses requires the cloned
cDNA of the eight viral genomic segments to be tran-
scribed into RNA of precise length without any additional
terminal nucleotides. In this study, we established a
method for rapid and reliable uniform cloning of inﬂuenza
A genes without any information about restriction sites.
Using this approach, we generated complete genomic sets
of eight plasmids from seven viral strains of diﬀerent
serotypes.
In the previously described modiﬁed Quikchange
TM
method (8), amplicons with a size of up to 1171nt had
been inserted between two adjacent nucleotides. However,
the two largest inﬂuenza virus genes, PB2 and PB1, com-
prise 2341nt each. Earlier attempts to insert them into
unmodiﬁed pHW2000 were not successful (data not
shown). The results obtained in this study suggest that
for longer inserts the exchange of a stretch, in this case
the ccdB gene within pHWSccdB as selectable marker, by
the PCR amplicon yields signiﬁcantly higher success rates
than direct insertion between two neighboured positions.
The cloning of several viral genes was performed using
the ccdB-sensitive TOP10 bacteria or ccdB-resistant
bacteria such as XL1-Blue
TM or SURE2
TM and the
highly processive Phusion
TM polymerase. In case of the
strain A/Thailand/1(KAN-1)/2004 (H5N1), the strain
XL1-Blue
TM was used except for the PB1 gene for which
the strain SURE2
TM had to be used. This observation
demonstrates that the negative selection against the
parent plasmid by using the ccdB marker can be replaced
by DpnI digestion commonly used in the Quikchange
TM
protocol. Earlier attempts to use either the original
pHW2000 plasmid or a modiﬁed version of this vector
containing the conserved inﬂuenza gene ends only or the
pHWSccdB plasmid together with Turbo-Pfu
TM polymer-
ase for cloning of the lengthy PB2 gene were not successful
(data not shown). However, when using the highly proces-
sive Phusion polymerase instead, the usage of vector
pHWSccdB led to positive clones. Therefore, a homology
of at least 20nt between amplicon ends and annealing sites
of the plasmid, a spacer between annealing sites, and the
high processivity of the used polymerase together are
essential for cloning of lengthier inserts.
The PCR primers used for ampliﬁcation of the full-
length inﬂuenza gene segments take advantage of the con-
served gene termini. These termini are identical for all
eight segments of all inﬂuenza A virus strains. Adjacent
to these termini are a few nucleotides identical in all virus
strains but gene-speciﬁc. Therefore, the universal inﬂuenza
primers, used in this study, modiﬁed from Hoﬀmann et al.
(11) diﬀer only by a few nucleotides at their 30-ends allow-
ing misampliﬁcation of other virus genes. These additional
amplicons contain mutations at these sites or may be frag-
mented and are therefore not suitable for cloning.
The 50-terminus of the cRNAs from the inﬂuenza A
virus polymerase genes PB2, PB1 and PA diﬀers from
that of the other viral genes by the nucleotide at position
4. Such minor diﬀerences can be addressed by appropriate
design of the PCR primers (Figure 1 and Table 1) and are
corrected during target-primed plasmid ampliﬁcation
demonstrating that complete homology between the
annealing sites of vector and amplicon is not required.
Suﬃcient amounts of insert (Table 2) are critical for
cloning eﬃciency via target-primed plasmid ampliﬁcation.
Otherwise, the rate of positive clones can decline consid-
erably. The Quikchange
TM method (developed by
Stratagene, La Jolla, CA, USA) yields circular nicked
molecules because the primers are not phosphorylated
and the primer annealing sites are situated at correspond-
ing positions on the two opposite strands of the plasmid
template. Therefore, the newly synthesized strands cannot
serve as template during following cycles because the
primer would anneal close to the 50-end of the template
in contrast to the PCR in which the primer annealing site
is situated at the 30-end. The products are two strands each
with one megaprimer strand as 50-end; these two strands
hybridize to nicked circular molecules. There are two
cyclic linear primer extensions from the two plasmid tem-
plate strands, but not an approximately exponential
ampliﬁcation as in the PCR. This linear ampliﬁcation
explains why such big amounts of PCR amplicon and
plasmid are necessary. Accordingly, attempts to use 20
cycles instead of 35 yielded no bacterial colonies after
transformation.
Another critical aspect for high eﬃciency is the protec-
tion of the PCR amplicon from short-waved UV light
during excision from the agarose gel. If no precautions
are taken, clones with repetitions of vector–insert junc-
tions may be isolated (data not shown). Moreover, PCR
amplicons have to be puriﬁed from agarose gels in order
to eliminate the cloning of polymerase gene segments with
large internal deletions. These aberrant products which
occur in defective interfering particles carry the same ter-
mini as the intact full-length genes (16,17). If present in
high frequency, they can interfere with eﬃcient ampliﬁca-
tion of intact polymerase gene segments. Moreover, they
can be eﬃciently integrated into the cloning vector by
target-primed plasmid ampliﬁcation even if they appear
only in trace amounts following PCR.
In summary, we established a novel method which can
be used for cloning of any inﬂuenza A virus strain inde-
pendent of restriction cleavage. This approach is based on
target-primed plasmid ampliﬁcation using the amplicons
of the inﬂuenza A gene segments as megaprimers. For
improvement, the plasmid vector and primer pairs were
adapted to each other: the conserved termini of the inﬂu-
enza A gene segments were integrated into the cloning
vector ﬂanking the negative selection marker ccdB.
These modiﬁcations could also be introduced into the vec-
tors of other reverse genetics systems for inﬂuenza A (3–6)
and B viruses (18,19). Provided that the termini of the
insert are only homologous to the annealing sites within
the plasmid vector and not to any other region within
vector or insert, this approach is also suitable for
PAGE 5 OF 6 Nucleic Acids Research, 2008, Vol. 36,No. 21 e139standardized cloning of any insert with conserved termini
without the need for prior sequence information.
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